Hospice visit number affects ability to die at home

June 27, 2012
Hospice visit number affects ability to die at home
Hospice patients with cancer are more likely to be able to die in the setting of their choice if they receive at least one hospice visit per day during the first four days of hospice care, according to research published online June 25 in the Journal of Clinical Oncology.

(HealthDay) -- Hospice patients with cancer are more likely to be able to die in the setting of their choice if they receive at least one hospice visit per day during the first four days of hospice care, according to research published online June 25 in the Journal of Clinical Oncology.

Neha Jeurkar, M.D., of the University of Pennsylvania Perelman School of Medicine in Lancaster, and colleagues conducted a retrospective, electronic health record-based cohort study involving 7,391 patients in three hospice programs in Pennsylvania, Florida, and Wisconsin. The authors sought to determine preferences and factors associated with an increased likelihood for to die at home.

The researchers found that patients who preferred to die at home were more than twice as likely to die at home. Factors associated with an increased likelihood of patients who preferred to die at home actually dying at home included having at least one visit per day in the first four days of , being married, and having an advance directive. Cancer patients with a higher functional status or who were experiencing moderate or severe pain were significantly less likely to die at home.

"The results of this study add to our understanding of the factors that facilitate death at home and highlight the importance of early visits by hospice team members," the authors write.

Two study authors are employed by Suncoast Solutions, which developed the electronic health record used by the hospices in the study.

Explore further: Supply of hospice services strongly associated with local area's median household income

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Supply of hospice services strongly associated with local area's median household income

May 9, 2011
Wealth, population size, race and age associate with the supply of hospice care available in a county, according to a study published in the Journal of Pain and Symptom Management this month.

Study finds race has an impact on both enrollment and disenrollment in hospice care

June 25, 2012
Although use of hospice services is increasing dramatically, a study led by Regenstrief Institute investigator Kathleen T. Unroe, M.D., MHA, an assistant research professor of medicine at the Indiana University School of ...

Ill, older patients who rely on emergency room often live final days in hospital, study finds

June 4, 2012
Half of adults over age 65 made at least one emergency department (ED) visit in the last month of life, in a study led by a physician at the San Francisco VA Medical Center (SFVAMC) and UCSF.

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.